GHST 最新10-Q变化
将 GHST 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-05-13 与上一份 10-Q · 2026-02-11
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +6 | −7 | ~3 | 10 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~1 | 1 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 风险因素 | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
| 其他信息 | 文字有新增/删除 | 0 | 0 | ~1 | 16 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-05-13
Fiscal Quarter Ended March 31, 2026 Compared to the Fiscal Quarter Ended March 31, 2025
We had revenues of $0 in the three months ended March 31, 2026 and $4,755 in the three months ended 2025, and we sustained net losses of $25,587 and $31,532, respectively, in those periods. During the three months ended March 31, 2026 and 2025, expenses consisted primarily of general and administrat…
Nine Months Ended March 31, 2026 Compared to the Nine Months Ended March 31, 2025
We had revenues of $13,852 in the nine months ended March 31, 2026 and $55,359 in the nine months ended 2025, and we sustained net losses of $75,740 and $89,963, respectively, in those periods.
Our total operating expenses were $90,412 and $145,322 during the nine months ended March 31, 2026 and 2025, respectively, reflecting decreased general and administrative expenses of $77,373 in the 2026 period compared to $136,358 in the 2025 period and an increase in patent development costs of $13…
相对上期删除的文字 · 来源:10-Q · 2026-02-11
Three Months Ended December 31, 2025 Compared to the Three Months Ended December 31, 2024
We had $10,367 primarily in revenue in the three months ended December 31, 2025 compared to $4,872 for the three months ended December 31, 2024, and we sustained net losses of $15,935 and $45,714, respectively, in those periods. The lower losses resulted from decreased operating expenses in the 2025…
During the three months ended December 31, 2025 and 2024, operating expenses were $26,302 and $50,586, respectively, which consisted of general and administrative expenses, including professional fees for legal and financial services, and patent development costs.
Six Months Ended December 31, 2025 Compared to the Six Months Ended December 31, 2024
We had $13,852 in revenue in the six months ended December 31, 2025 compared to $50,604 for the six months ended December 31, 2024, and we sustained net losses of $50,153 and $58,431, respectively, in those periods.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议